377 related articles for article (PubMed ID: 16412856)
1. Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure.
Sola S; Mir MQ; Lerakis S; Tandon N; Khan BV
J Am Coll Cardiol; 2006 Jan; 47(2):332-7. PubMed ID: 16412856
[TBL] [Abstract][Full Text] [Related]
2. HMG CoA reductase inhibition and left ventricular mass in hypertrophic cardiomyopathy: a randomized placebo-controlled pilot study.
Bauersachs J; Störk S; Kung M; Waller C; Fidler F; Hoyer C; Frantz S; Weidemann F; Ertl G; Angermann CE
Eur J Clin Invest; 2007 Nov; 37(11):852-9. PubMed ID: 17973781
[TBL] [Abstract][Full Text] [Related]
3. Long-term statin therapy in patients with systolic heart failure and normal cholesterol: effects on elevated serum markers of collagen turnover, inflammation, and B-type natriuretic peptide.
Abulhul E; McDonald K; Martos R; Phelan D; Spiers JP; Hennessy M; Baugh J; Watson C; O'Loughlin C; Ledwidge M
Clin Ther; 2012 Jan; 34(1):91-100. PubMed ID: 22154198
[TBL] [Abstract][Full Text] [Related]
4. Statins do not significantly affect muscle sympathetic nerve activity in humans with nonischemic heart failure: a double-blind placebo-controlled trial.
Horwich TB; Middlekauff HR; Maclellan WR; Fonarow GC
J Card Fail; 2011 Nov; 17(11):879-86. PubMed ID: 22041323
[TBL] [Abstract][Full Text] [Related]
5. The effects of atorvastatin (10 mg) on systemic inflammation in heart failure.
Mozaffarian D; Minami E; Letterer RA; Lawler RL; McDonald GB; Levy WC
Am J Cardiol; 2005 Dec; 96(12):1699-704. PubMed ID: 16360360
[TBL] [Abstract][Full Text] [Related]
6. Atorvastatin therapy is associated with reduced levels of N-terminal prohormone brain natriuretic peptide and improved cardiac function in patients with heart failure.
Stypmann J; Schubert A; Welp H; Schulte H; Assmann G; Breithardt G; Nofer JR
Clin Cardiol; 2008 Oct; 31(10):478-81. PubMed ID: 18855352
[TBL] [Abstract][Full Text] [Related]
7. Atorvastatin improves endothelial function and cardiac performance in patients with dilated cardiomyopathy: the role of inflammation.
Liu M; Wang F; Wang Y; Jin R
Cardiovasc Drugs Ther; 2009 Oct; 23(5):369-76. PubMed ID: 19636689
[TBL] [Abstract][Full Text] [Related]
8. Atorvastatin enhances interleukin-10 levels and improves cardiac function in rats after acute myocardial infarction.
Stumpf C; Petzi S; Seybold K; Wasmeier G; Arnold M; Raaz D; Yilmaz A; Daniel WG; Garlichs CD
Clin Sci (Lond); 2009 Jan; 116(1):45-52. PubMed ID: 18459941
[TBL] [Abstract][Full Text] [Related]
9. Atorvastatin treatment improves endothelial function through endothelial progenitor cells mobilization in ischemic heart failure patients.
Oikonomou E; Siasos G; Zaromitidou M; Hatzis G; Mourouzis K; Chrysohoou C; Zisimos K; Mazaris S; Tourikis P; Athanasiou D; Stefanadis C; Papavassiliou AG; Tousoulis D
Atherosclerosis; 2015 Feb; 238(2):159-64. PubMed ID: 25525743
[TBL] [Abstract][Full Text] [Related]
10. Atorvastatin increases plasma soluble Fms-like tyrosine kinase-1 and decreases vascular endothelial growth factor and placental growth factor in association with improvement of ventricular function in acute myocardial infarction.
Kodama Y; Kitta Y; Nakamura T; Takano H; Umetani K; Fujioka D; Saito Y; Kawabata K; Obata JE; Mende A; Kobayashi T; Kugiyama K
J Am Coll Cardiol; 2006 Jul; 48(1):43-50. PubMed ID: 16814647
[TBL] [Abstract][Full Text] [Related]
11. Long-term effect of atorvastatin on neurohumoral activation and cardiac function in patients with chronic heart failure: a prospective randomized controlled study.
Yamada T; Node K; Mine T; Morita T; Kioka H; Tsukamoto Y; Tamaki S; Masuda M; Okuda K; Fukunami M
Am Heart J; 2007 Jun; 153(6):1055.e1-8. PubMed ID: 17540209
[TBL] [Abstract][Full Text] [Related]
12. The influence of atorvastatin on parameters of inflammation and function of the left ventricle in patients with dilated cardiomyopathy.
Bielecka-Dabrowa A; Goch JH; Mikhailidis DP; Rysz J; Maciejewski M; Banach M
Med Sci Monit; 2009 Dec; 15(12):MS12-23. PubMed ID: 19946241
[TBL] [Abstract][Full Text] [Related]
13. Atorvastatin therapy during the peri-infarct period attenuates left ventricular dysfunction and remodeling after myocardial infarction.
Tang XL; Sanganalmath SK; Sato H; Bi Q; Hunt G; Vincent RJ; Peng Y; Shirk G; Dawn B; Bolli R
PLoS One; 2011; 6(9):e25320. PubMed ID: 21980426
[TBL] [Abstract][Full Text] [Related]
14. Effect of atorvastatin on plasma NT-proBNP and inflammatory cytokine expression in patients with heart failure.
Duan HY; Liu DM; Qian P; Wang SL; Yan LJ; Wu JT; Yang HT; Fan XW; Chu YJ
Genet Mol Res; 2015 Dec; 14(4):15739-48. PubMed ID: 26634541
[TBL] [Abstract][Full Text] [Related]
15. Pleiotropic effects of atorvastatin in heart failure: role in oxidative stress, inflammation, endothelial function, and exercise capacity.
Castro PF; Miranda R; Verdejo HE; Greig D; Gabrielli LA; Alcaino H; Chiong M; Bustos C; Garcia L; Mellado R; Vukasovic JL; Godoy I; Lavandero S
J Heart Lung Transplant; 2008 Apr; 27(4):435-41. PubMed ID: 18374881
[TBL] [Abstract][Full Text] [Related]
16. Double-blind, randomized, placebo-controlled study of high-dose HMG CoA reductase inhibitor therapy on ventricular remodeling, pro-inflammatory cytokines and neurohormonal parameters in patients with chronic systolic heart failure.
Krum H; Ashton E; Reid C; Kalff V; Rogers J; Amarena J; Singh B; Tonkin A
J Card Fail; 2007 Feb; 13(1):1-7. PubMed ID: 17338996
[TBL] [Abstract][Full Text] [Related]
17. Impact of intensive statin use on the level of inflammation and platelet activation in stable angina after percutaneous coronary intervention: a clinical study.
Li Q; Deng SB; Xia S; Du JL; She Q
Med Clin (Barc); 2013 Jun; 140(12):532-6. PubMed ID: 23177313
[TBL] [Abstract][Full Text] [Related]
18. Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase.
Landmesser U; Engberding N; Bahlmann FH; Schaefer A; Wiencke A; Heineke A; Spiekermann S; Hilfiker-Kleiner D; Templin C; Kotlarz D; Mueller M; Fuchs M; Hornig B; Haller H; Drexler H
Circulation; 2004 Oct; 110(14):1933-9. PubMed ID: 15466656
[TBL] [Abstract][Full Text] [Related]
19. Effect of atorvastatin on non-ischemic heart failure and matrix metalloproteinase-2 and 9 in rats.
Cheng G; Xu G; Cai HW; Wang HH; Bao XF
Acta Pharmacol Sin; 2007 Apr; 28(4):511-7. PubMed ID: 17376290
[TBL] [Abstract][Full Text] [Related]
20. Effects of atorvastatin on inflammatory and fibrinolytic parameters in patients with chronic kidney disease.
Goicoechea M; de Vinuesa SG; Lahera V; Cachofeiro V; Gómez-Campderá F; Vega A; Abad S; Luño J
J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S231-5. PubMed ID: 17130267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]